Barbara Kosacz's Net Worth
$805 Thousand
Who is Barbara Kosacz?
Barbara Kosacz does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include XOMA Corp, CERO THERAPEUTICS HOLDINGS, INC., Athira Pharma, Inc., Kronos Bio, Inc., and Locust Walk Acquisition Corp..
SEC CIK
Barbara Kosacz's CIK is 0001763316
Past Insider Trading and Trends
2022 was Barbara Kosacz's most active year for acquiring shares with 5 total transactions. Barbara Kosacz's most active month to acquire stocks was the month of April. 2024 was Barbara Kosacz's most active year for disposing of shares, totalling 1 transactions. Barbara Kosacz's most active month to dispose stocks was the month of December. 2020 saw Barbara Kosacz paying a total of $99,750.00 for 185,962 shares, this is the most they've acquired in one year. In 2024 Barbara Kosacz cashed out on 10,676 shares for a total of $12,636.11, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
XOMA Corp (XOMA) Snapshot price: $28.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CERO THERAPEUTICS HOLDINGS, INC. (PBAX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.83K |
—
|
—
| 5.83K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Athira Pharma, Inc. (ATHA) Snapshot price: $0.5407
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
COO & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.14% | -10.68K |
$1.18 | -$12,636.11 | 928.97K |
Jan 4
| |||
Form 4
| +17.35% | 138.91K |
—
|
—
| 939.64K |
Feb 15
| |||
Form 4
| +7.26% | 53.6K |
—
|
—
| 791.62K |
Jul 25
| |||
Form 4
| +7.83% | 53.6K |
—
|
—
| 738.02K |
Feb 15
| |||
Form 4
| +11.36% | 69.82K |
—
|
—
| 684.42K |
Dec 9
| |||
Form 4
| +0.86% | 5.25K |
$19.00 | $99,750.00 | 614.6K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Locust Walk Acquisition Corp. (EFTR) Snapshot price: $0.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||